Olivia
Online
sam hockerfield
@HockerfieldSam
Joined December 2020
21 Following
115 Followers
447 Posts
❤️🙏 ANOTHER MRI. ANOTHER ANSWERED PRAYER!
NO EVIDENCE OF DISEASE!!! 🎉❤️
Today, Braelyn had another brain MRI, and I am absolutely OVERJOYED to share that it once again showed NO EVIDENCE OF DISEASE!
NO CHANGE from her August MRI!
And just FOUR DAYS AGO, on Friday, November 6, Braelyn received her 5th DCVax-L treatment in London! 🇬🇧
I cannot begin to describe the emotions.
After more than three years of fighting this devastating brain cancer, three major brain tumor surgeries, radiation, countless treatments, and more fear than I ever imagined a mother could endure, we are now celebrating another MRI showing NO EVIDENCE OF DISEASE!
I wish I could tell you that the scanxiety gets easier. But it doesn’t. At least not for me.
Every MRI brings back the memories of devastating scans, heartbreaking news, and the terrifying uncertainty of what might come next.
I still find myself holding my breath, praying desperately for those words.
And today, we heard them again.
NO EVIDENCE OF DISEASE. ❤️🙏
My heart is overflowing with gratitude.
To every single person who has prayed for Braelyn, supported our family, donated to help make her treatments possible, shared her story, or simply sent us words of encouragement—THANK YOU!
You have helped carry us through the darkest days of our lives, and you are now helping us celebrate some of the brightest.
And to Northwest Biotherapeutics ($NWBO), the brilliant Dr. Linda Liau at UCLA, and the extraordinary Professor Keyoumars Ashkan at King’s College Hospital—there are simply no words adequate to express our gratitude.
Thank you for your dedication, your compassion, and your determination to bring new hope to patients facing this devastating disease.
Braelyn is 19 years old. She’s attending college. She’s dreaming about her future.
And today, once again, her MRI shows NO EVIDENCE OF DISEASE!
GOD IS GOOD! ❤️🙏
#DCVax #BrainCancer #BraelynsFight #NoEvidenceOfDisease
#DCvaxForBraelyn
Made in America. Banned in America.
Braelyn's scans are clear thanks to an American treatment, one she has to fly to the UK to get. In Clemson, she told President Trump her story.
No American should need a passport to get an American treatment. #RightToTry
Stephen Moore’s Post

Stephen Moore
4d
Made in America. Banned in America.
Let me tell you about a remarkable young woman named Braelyn.
She was diagnosed with brain cancer at 16. Today she's 19, and her scans are clear. The treatment that got her there was invented by an American company, with American science and American ingenuity.
Here's the outrage: Braelyn can't get it here. She has to travel to the UK for treatment.
Think about that. We lead the world in medical innovation, and then we make our own citizens leave the country to benefit from it. The British are getting American breakthroughs that Americans can't. That isn't a free market. That's a regulatory roadblock, and it costs lives.
President Trump understood this when he signed Right to Try in 2018. The idea was simple: if you're facing a life-threatening diagnosis, Washington shouldn't stand between you and a treatment that might save you. It was one of the best things he did in his first term. But Braelyn's story tells me the job isn't finished. The promise of Right to Try still isn't reaching the patients who need it most. When the President came to Clemson, South Carolina, for a rally near Braelyn's home, our team made sure she was there. Braelyn got her moment with the President, and he heard her story.
Now it's Washington's turn. Make Right to Try work the way it was meant to. Put American cancer vaccine breakthroughs in the NCI Cancer Vaccine Initiative. And stop exporting our breakthroughs while our patients wait.
No American should need a passport to get an American treatment.
Bring it home.
Thank you to Braelyn and her family for their courage in sharing her story.
#RightToTry #BringItHome #UnleashProsperity
#DCvaxForBraelyn
🇺🇸❤️ BIG NEWS & A LITTLE EXTRA HOPE! 🙏
We’re headed back to London for Braelyn’s next DCVax treatment, but this trip feels different!
This past week, I had the incredible opportunity to speak personally with @DrOz!
He’s been discussing Braelyn’s case with the FDA, and we’re exploring possible pathways to bring her ongoing DCVax treatments HOME to America!
Could Braelyn’s next treatment in MARCH actually happen right here in the USA?! 🇺🇸
Nothing is finalized, but some very important doors may be opening!
Please watch, share, and keep praying! ❤️🙏
#DCvaxForBraelyn
#BraelynsFight
@DrOzCMS
Looking forward to this conference today! Signed up to attend virtually.
https://t.co/ByPtfNcyow
They are discussing DC-VAX at FDA Rare Disease Conference $NWBO
🚨🇺🇸 BRAELYN’S STORY JUST MADE FOX BUSINESS! 🇺🇸🚨
What an incredible moment for our family!
Today on Varney & Co., Stuart Varney brought up Steve Moore’s recent Rasmussen Reports article about Braelyn and the barriers seriously ill Americans face in accessing promising experimental treatments!
Steve shared Braelyn’s story and called out the FDA, saying it’s CRUEL to withhold promising investigational treatments from desperately ill patients.
Varney agreed, arguing that patients facing terminal illnesses should have the freedom to accept the risks of experimental treatments without liability concerns preventing companies from providing them.
Then Steve asked a powerful question:
“Whatever happened to my body, my choice?”
He also pointed out that President Trump supports Right to Try, yet significant barriers remain between patients and the treatments they desperately need.
THIS is the conversation we’ve been fighting to bring into the national spotlight!
Our 19-year-old daughter is attending college, and her latest MRI shows no evidence of cancer recurrence. Yet we still have to travel to ENGLAND for her ongoing DCVax-L treatments—developed right here in AMERICA!
We are so incredibly grateful to Steve Moore and Stuart Varney for bringing attention to Braelyn’s story and, more importantly, to the countless patients who deserve a fighting chance.
Patients facing life-threatening illnesses shouldn’t have to fight their own government for the opportunity to fight for their lives.
PLEASE WATCH AND SHARE! ❤️🙏
@realDonaldTrump @DrOzCMS @SecKennedy
#DCVaxForBraelyn #RightToTry #DCVax
#BraelynsFight
$NWBO
$nwbo. They just brought up dcvax and Braelyn on Fox business. Stephen Moore.
❤️ SUNDAY MORNING UPDATE — WE’RE GETTING SO CLOSE! ❤️
In just 12 days, Braelyn will receive her next DCVax-L treatment in London!
Since my last fundraising update, more generous people have stepped forward to help us continue her treatment. We are overwhelmed by your kindness and generosity!
I’ve carefully reconciled our treatment fund, GoFundMe, GiveSendGo, and private donations to share where we stand.
🎯 Estimated November 6 treatment cost: $30,844
❤️ TOTAL FUNDS ACCOUNTED FOR: $26,308.02
🎯 ESTIMATED AMOUNT STILL NEEDED: $4,535.98
That’s more than 85% of November’s treatment covered!
These figures include donations already deposited, contributions still processing through our fundraising platforms, and private gifts received but not yet deposited.
Because treatment is billed in British pounds, the final dollar amount may vary slightly depending on exchange rates and fees.
When I look at Braelyn today—cancer-free, attending college, and looking forward to her future—I am reminded why we continue fighting so hard for access to DCVax-L.
Thank you to everyone who has donated, shared her story, prayed for her, or encouraged our family. Your generosity has helped make this journey possible.
We’re getting so close to covering her November treatment!
If you’re able to help us close the remaining gap, we would be incredibly grateful. Every donation, regardless of size, and every share makes a difference.
Thank you for helping give Braelyn hope and a future. ❤️🙏
#DCVaxForBraelyn #DCVax #BrainCancer
❤️ TWO WEEKS UNTIL WE RETURN TO LONDON! ❤️
In just two weeks, Braelyn and I will be heading back to the UK for her next round of DCVax treatments!
First, I want to say THANK YOU to every single person who has donated, shared our story, prayed for Braelyn, or helped us in ways you may never fully realize. The kindness and generosity of this incredible community continue to overwhelm me. ❤️
Thanks to YOU, we’ve raised $19,094 toward the $30,600 needed for November’s treatments!
That leaves us just $11,506 away from our goal!
I also want to share something wonderful. An incredibly generous private donor has graciously covered our airfare and lodging for this trip! What an extraordinary blessing! This means every dollar of our $30,600 fundraising goal is dedicated to Braelyn’s treatments.
Because Advent requires payment in advance, we’re working hard to raise the remaining funds before we leave.
Three years ago, we were told there was little hope for our daughter. Today, Braelyn is 19, attending college, living her life, and her latest MRI shows NO EVIDENCE OF DISEASE! 🙏❤️
We have SO MUCH to celebrate and SO MUCH to be thankful for!
If you’re able to donate, we would be incredibly grateful. And if you can’t, sharing our story is an enormous gift in itself.
From the bottom of this mama’s heart, THANK YOU for continuing to stand beside Braelyn. We’re not just fighting for her future. We’re fighting for a future where other families have access to the same hope.
❤️🙏
#DCVaxForBraelyn #GBM #BrainCancer #DCVax
https://t.co/uMICOowgL2
We wouldn’t be here today, with Braelyn regaining her health and our family fighting for change in our healthcare system and government if it weren’t for you, Dr. Andrew and the incredible $NWBO / DCvax community. Forever grateful.
🇺🇸❤️ WE MET PRESIDENT TRUMP TONIGHT! ❤️🇺🇸
What an extraordinary evening for our family!
Tonight, Braelyn, Ben, and I had the incredible opportunity to meet President Trump at the rally in Pendleton, South Carolina!
We had only about 20–30 seconds with him, and I knew I needed to make every second count.
I introduced him to Braelyn and thanked him for telling Dr. Oz about her brain cancer story.
I explained that Braelyn had been diagnosed with glioblastoma, the deadliest type of brain tumor, but that today she is CANCER-FREE after receiving DCVax-L, a personalized cancer vaccine developed right here in America!
Yet we must travel all the way to England for her ongoing treatments because we cannot access it here in the United States.
Then something pretty cool happened!
President Trump turned to one of his staffers and instructed them to get me in touch with Dr. Oz!
I also expressed my hope that we could connect with Secretary Kennedy.
As our brief time together came to an end, I made one final appeal:
“Please help bring this American-made treatment back home to America.”
President Trump was incredibly gracious to our family and very kind to Braelyn. We are so grateful for the opportunity to speak with him!
Earlier in the evening, I was also able to give a member of his staff a detailed packet about Braelyn’s journey, DCVax-L, and the obstacles American patients face in accessing promising investigational treatments.
Now we are praying that the connection with Dr. Oz comes through!
Three years ago, Braelyn was given just months to live. Today, she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE!
Tonight, we had the opportunity to bring her story directly to the President of the United States. ❤️
My prayer is that this opens the door to a much bigger conversation—one that could change the future for countless American cancer patients.
📸 We were not permitted to bring our phones into the private meeting with President Trump, so we couldn’t take our own pictures with him. His staff took an official photograph of us together, which we’re told will be emailed to us. I can’t wait to share it! In the meantime, here are some pictures from our unforgettable evening.
Thank you to EVERYONE who helped make tonight possible and to all of you who continue to share Braelyn’s story. You helped us get this far, and we’re not stopping now! ❤️🙏
@realDonaldTrump @DrOzCMS @WhiteHouse
#DCVaxForBraelyn #DCVax
❤️ IT’S OFFICIAL! WE’RE MEETING PRESIDENT TRUMP TOMORROW! 🇺🇸
Braelyn and I have been invited to attend tomorrow’s rally for Darline Graham in Clemson! We’ll be seated in the VIP section AND have the opportunity to meet President Trump in the “click line”!
Ben is cutting his work trip short, and we’re hoping he’ll make it home in time to join us!
We’ll have only seconds with the President, but I intend to make every one of them count. I’ll also be bringing information for him and his staff about Braelyn, DCVax-L, and the barriers American patients face trying to access promising treatments developed right here in the United States.
This is an extraordinary opportunity, but we’re hoping it can become something even bigger.
PLEASE HELP US GET THE ATTENTION OF THE WHITE HOUSE PRESS TEAM! 🙏
We would love the opportunity for a longer conversation with President Trump or his administration about how we can make these treatments accessible to American patients.
Please SHARE, REPOST, and TAG anyone who might help get Braelyn’s story in front of the right people!
Three years ago, Braelyn was given just months to live. Today she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE!
Her story deserves to be heard. And so do the stories of countless other patients fighting for access to promising treatments.
@realDonaldTrump @DrOzCMS @WhiteHouse
#DCVaxForBraelyn #DCVax #PresidentTrump
$NWBO | ACCOUNTABILITY REQUIRES A VOICE
I sent Professor Anthony Chalmers, who is leading the UK’s brain cancer review, a detailed, evidence-based letter urging a comprehensive assessment of DCVax-L, including the latest clinical findings and developments.
I’m sharing that letter publicly for a reason.
Decision-makers need to know we are paying attention. We follow the science, understand the evidence, ask informed questions, and are willing to speak up.
Silence gives those in authority too much latitude to make decisions without meaningful scrutiny. It also leaves room for outside influences and unchallenged assumptions to shape outcomes.
Speaking up isn’t interference. It’s accountability.
We are not asking anyone to abandon scientific standards. We are insisting that those standards be applied fairly, consistently, and transparently.
Scrutiny cannot stop at the treatment. It must extend to the decisions that determine whether patients ever gain access to it.
For Braelyn. For every patient and family waiting for better options.
Our voices deserve to be heard. The evidence deserves to be examined. And every decision deserves accountability.
$NWBO #DCVax #DCVaxForBraelyn #GBM #Glioblastoma #BrainCancer #BTSM #Immunotherapy #PatientAccess
$NWBO $NVCR
Yesterday, UK Prime Minister Andy Burnham announced an expert review of brain cancer research, led by Professor Anthony Chalmers. It will assess progress since 2018, identify barriers slowing the development of new treatments, and report within three months.
The government plans to use the findings to create a national action plan, appoint a national clinical lead for brain cancer, and shorten the MHRA’s review of rules for medicines treating rare conditions from three years to two.
Transparency matters:
ASCO’s 2026 disclosure for Professor Anthony Chalmers lists consulting or advisory relationships with Novocure, AbbVie, Bristol Myers Squibb, Janssen, Lilly, Roche, Servier, Stemline Therapeutics, and Voyager Therapeutics. A glioblastoma study also disclosed AstraZeneca research funding, honoraria, and advisory-board involvement.
As Dr Chalmers leads a government review on brain cancer, the public should know how these interests will be managed.
Sources: https://t.co/32UVJTo3H4
https://t.co/I5ZssKv8YE
@Siobhain_Mc
@10DowningStreet
@BBC
@BrainTumourOrg
@Telegraph
@DailyMail
@RichFairgrieve
@biggercapital
@kshaughnessy2
@greta
@peterjkostis
@HollensbeAmanda
@zubirahmed
$NWBO 𝗗𝗖𝗩𝗮𝘅-𝗟: 𝗡𝗛𝗦𝗕𝗧 𝗖𝗢𝗟𝗟𝗘𝗖𝗧𝗜𝗢𝗡𝗦 𝗔𝗥𝗘 𝗟𝗜𝗩𝗘. 𝗖𝗨𝗥𝗥𝗘𝗡𝗧 𝗔𝗖𝗖𝗘𝗦𝗦 𝗔𝗡𝗗 𝗖𝗢𝗠𝗠𝗘𝗥𝗖𝗜𝗔𝗟 𝗣𝗥𝗘𝗣𝗔𝗥𝗔𝗧𝗜𝗢𝗡 𝗔𝗥𝗘 𝗠𝗢𝗩𝗜𝗡𝗚 𝗧𝗢𝗚𝗘𝗧𝗛𝗘𝗥.
I contacted NHSBT directly to clarify what is operational, how patients enter the pathway, and what the collaboration is intended to support.
Their response confirms:
“Yes, the service is currently live and collections have already begun.”
𝗟𝗲𝗲𝗱𝘀 𝗮𝗻𝗱 𝗢𝘅𝗳𝗼𝗿𝗱 𝗮𝗿𝗲 𝗼𝗽𝗲𝗻. DCVax-L patient collections through NHSBT are happening now.
𝗕𝗢𝗧𝗛 𝗕𝗘𝗙𝗢𝗥𝗘 𝗔𝗡𝗗 𝗔𝗙𝗧𝗘𝗥 𝗔𝗣𝗣𝗥𝗢𝗩𝗔𝗟
I specifically asked whether the collaboration supports existing compassionate-use/unlicensed treatment arrangements, preparation for commercial rollout following MHRA marketing authorisation, or both.
The answer:
“Both.”
That establishes the purpose of this infrastructure: serving patients under current access arrangements while preparing to support commercial use following an approval.
𝗘𝗫𝗣𝗔𝗡𝗦𝗜𝗢𝗡 𝗜𝗦 𝗣𝗥𝗢𝗕𝗔𝗕𝗟𝗘 𝗕𝗘𝗙𝗢𝗥𝗘 𝗠𝗔𝗥𝗞𝗘𝗧𝗜𝗡𝗚 𝗔𝗨𝗧𝗛𝗢𝗥𝗜𝗦𝗔𝗧𝗜𝗢𝗡
NHSBT’s exact wording:
“Expansion is probable in advance of marketing authorisation.”
Additional sites and potential start dates are already being negotiated. NHSBT said these details can be shared once confirmed.
This means network development can progress before a regulatory decision. Leeds and Oxford are the two locations confirmed operational today; further locations are being actively discussed.
𝗧𝗛𝗘 𝗦𝗖𝗔𝗟𝗜𝗡𝗚 𝗦𝗜𝗚𝗡𝗜𝗙𝗜𝗖𝗔𝗡𝗖𝗘
NWBO and Advent already have functioning collection services within established NHSBT clinical infrastructure. Additional locations would extend that pathway geographically, connecting more patients with an essential step in personalised vaccine production.
Current patient access, operational experience and preparation for broader commercial use are developing together.
The email establishes a live service and an active expansion process. DCVax-specific annual collection capacity and manufacturing throughput were not provided.
𝗔 𝗖𝗢𝗡𝗖𝗥𝗘𝗧𝗘 𝗧𝗜𝗠𝗘𝗙𝗥𝗔𝗠𝗘 𝗔𝗡𝗗 𝗥𝗘𝗙𝗘𝗥𝗥𝗔𝗟 𝗥𝗢𝗨𝗧𝗘
NHSBT says it can usually accommodate a patient within 𝟮 𝘄𝗲𝗲𝗸𝘀.
The referral pathway is:
𝗥𝗲𝗳𝗲𝗿𝗿𝗶𝗻𝗴 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝘁 → 𝗔𝗱𝘃𝗲𝗻𝘁 𝗕𝗶𝗼𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 → 𝗡𝗛𝗦𝗕𝗧.
The consultant contacts Advent, which then makes the NHSBT referral. Physicians have an identified route into the collection service.
The two-week timeframe applies to NHSBT’s stage. Advent’s separate waiting time was not confirmed, so the complete schedule through assessment, manufacturing and treatment still needs clarification.
𝗛𝗢𝗪 𝗖𝗨𝗥𝗥𝗘𝗡𝗧 𝗔𝗖𝗖𝗘𝗦𝗦 𝗜𝗦 𝗙𝗨𝗡𝗗𝗘𝗗
NHSBT confirmed that patients currently self-fund treatment because it is not commissioned by NHS England.
NHSBT is delivering services within that pathway. Its participation does not establish NHS-funded treatment. Patient charges and NHSBT’s financial terms were not disclosed.
𝗧𝗛𝗘 “𝗔𝗟𝗟 𝗦𝗢𝗟𝗜𝗗 𝗧𝗨𝗠𝗢𝗨𝗥𝗦” 𝗤𝗨𝗘𝗦𝗧𝗜𝗢𝗡
My question about this wording, current patient eligibility and its relationship to the MHRA application was referred to Simon Cliffe for clarification.
Her reply did not establish the scope of current eligibility across tumour types or a future approved indication.
𝗜 𝗛𝗔𝗩𝗘 𝗔𝗟𝗥𝗘𝗔𝗗𝗬 𝗦𝗘𝗡𝗧 𝗔 𝗙𝗢𝗟𝗟𝗢𝗪-𝗨𝗣
I am a physician and independent patient advocate. I do not work for NWBO or Advent. I am receiving substantial enquiries from patients and families, including people in the United States interested in UK access.
I have sent another email asking for:
• The appropriate Advent contact and a coordinator for the complete pathway.
• Whether US physicians can initiate referrals directly or patients first need a UK consultant.
• When NHSBT’s two-week timeframe begins, plus separate assessment and manufacturing waiting times.
• Whether eligibility, tumour-tissue suitability, costs and appointments can be confirmed before international travel, and how many UK visits are required.
• A written referral checklist that can be shared with patients and their physicians.
Jemima also offered a call, which I welcomed in my reply. My aim is to help patients and their doctors understand the complete process and coordinate access to this operating service.
Source: written correspondence with Jemima Churchhouse, Service Development Manager, NHSBT Therapeutic Apheresis Services, 12 October 2026.
#DCVax #GBM #CancerImmunotherapy #UKLifeSciences #DCVaxForBraelyn
Out of respect for the person who took the time to respond, I’m keeping direct screenshots of the email off X. I’m sharing the substantive information provided and am awaiting a response to my follow-up questions. I’ll share further clarification when I receive it.
$NWBO Hard to believe they NHS would not know status of MHRA application for DCVAX
I started finding more long-term survivors.
This was probably the biggest change in my thinking.@ThomasOwenMcCa1 wasn’t alone.
Brad Silver received DCVax-L in one of the earliest trials after being diagnosed with GBM in his early 30s. He’s now a 23-year survivor.
Jamil Newirth was diagnosed at 32 and given approximately 17 months to live. He received UCLA’s personalized dendritic-cell vaccine and was profiled by UCLA more than a decade later, alive and thriving.
Sarah Rigby was diagnosed with GBM in 2011 and has been documented more than 15 years later as a long-term DCVax patient.
Nigel French was diagnosed with GBM in 2015, entered the DCVax-L trial at King’s College Hospital and was subsequently documented in long-term remission.
Kat Charles was diagnosed with grade 4 GBM in 2013 and at one point was told she had only three months to live. She later obtained a personalized dendritic-cell vaccine and continued receiving maintenance booster injections. More than a decade later, hers remains an extraordinary long-term-survivor story.
And I found other early UCLA dendritic-cell-vaccine survivors, including Jennifer Sugioka, Elijah Luyten and Gallia Kistler.
Suddenly Thomas didn’t look like one isolated anomaly anymore.
I was finding a group of people who had received this type of dendritic-cell vaccine and experienced extraordinary survival — 10 years, 12 years, 20-plus years — including patients with many years without recurrence.
And there is something especially important about these early survivors:
Many of them didn’t receive Hiltonol.
Some were treated years before the later UCLA study combining dendritic-cell vaccination with poly-ICLC.
In other words, the extraordinary long-term survivors already existed before these newer combinations were being used.
And that made the newer research even more exciting to me.
If some patients became 10-, 15- and even 20-plus-year survivors with the earlier vaccine approaches, what might be possible if researchers can now strengthen that immune response even further?
That’s the question that gives me hope.
Then came Marnix Bosch’s July 3, 2026 presentation.
At the British Neuro-Oncology Society meeting, Bosch presented new analyses using individual-patient data that hadn’t been available for the original Phase III analysis.
Researchers were now able to match DCVax patients much more precisely with patients from three randomized GBM trials based on important prognostic characteristics.
Across several propensity-score-matching approaches, the estimated survival advantage associated with DCVax-L was 3.4 to 6.3 months, rather than the original 2.8 months. Other statistical approaches produced similar results.
Their overall conclusion was that the original analysis had likely underestimated the survival benefit associated with DCVax-L.
Was that encouraging to me?
Absolutely.
But I want to be honest: an extra handful of months still isn’t what gives me hope.
Whether the median advantage is three months or six months, I don’t want six extra months for my daughter.
I want her to live a long, full life.
What the newer analysis did was strengthen my confidence that DCVax has a real treatment effect and that its original benefit may have been underestimated.
But my hope comes from the long tail.
At five years, 13% of newly diagnosed GBM patients receiving DCVax were alive compared with 5.7% of the external controls — more than double.
And now I know of some of the people represented by that tail.
Brad.
Thomas.
Jamil.
Sarah.
Nigel.
Kat.
Jennifer.
Elijah.
Gallia.
Those are the people I think about.
To get through November’s cancer treatment, this family needs about $25,000 right now…can you all help a bit and contribute? With crowd sharing (all of us paying a little), we can save this girl’s life…thank you so much https://t.co/P7Rf8eeob5
Last Seen Users on Sotwe
Ranni
Seen from Malaysia
anjai
Seen from Indonesia
𝐃𝐚𝐝𝐝𝐲'𝐬 𝐠𝐢𝐫𝐥☁️
Seen from Turkey
9700
Seen from United States
Konsept Porn -Kaliteli Konulu Yetişkin Videoları
Seen from Turkey
快递分拣员阿B
Seen from Germany
gilatante
Seen from Indonesia
chapinas
Seen from Guatemala
Mê cu trai thẳng 🤤
Seen from Vietnam
Elver
Seen from Panama
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.3M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers